We are monitoring the impact of COVID-19 on Europe Alopecia Market Get in touch with us for detailed analysis Know More
Pulished Date September, 2021
ID: 12203
Share on
Share on

Europe Alopecia Market Research Report – Segmented By Disease, Treatment, Gender, Sales channel, End Use, & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast | 2021 to 2026

Pulished: September, 2021
ID: 12203
Pages: 100

Europe Alopecia Market Size (2021 to 2026)

The Europe Alopecia Market was worth USD 2.65 billion in 2021 and is estimated to be growing at a CAGR of 7.96%, to reach USD 3.89 billion by 2026.

Alopecia is a medical condition that refers to sudden, excessive hair loss on the head area, mostly in circular patches. One such type of alopecia - Alopecia areata is a common autoimmune disease that causes baldness that results in partial or complete hair loss

Due to an increase in the prevalence of alopecia conditions such as androgenic alopecia, alopecia areata, alopecia totalis, and others, as well as an increase in the prevalence of chemotherapy-induced alopecia, the European alopecia market is expected to grow significantly during the forecast period. High levels of stress, hormonal imbalance, an increase in the usage of alcohol and cigarettes, and a shift in eating patterns all contribute to the market's growth. The ability of hair renewal is enhanced by cytokine therapy, which causes hair follicle cells to differentiate and proliferate while managing the hair growth cycle. Combination therapy has also been shown to be clinically effective in the treatment of alopecia. Combination therapies are now the most often used hair loss treatment.

The Europe alopecia treatment market is projected to be hampered by the patent expiration of many blockbuster medications and the adverse effects associated with existing hair loss treatment techniques. The increasing demand for hair loss treatment pharmaceuticals with improved effectiveness and low side effects is propelling the European alopecia market forward. For example, cytokine therapy and regenerative cell therapy have become increasingly popular in recent years for the treatment of various kinds of alopecia.

Changing lifestyle patterns, an increase in the frequency of autoimmune diseases, high levels of alcohol and smoking, and an aging population are all contributing to the growth of the Europe alopecia treatment market. Increased personal care spending and customer knowledge of hair growth product quality are also critical for the French market's growth. As a result, these factors are expected to fuel the expansion of the European alopecia (hair loss) market over the forecast period. In the coming years, the global androgenetic alopecia therapy market is likely to be driven by an increase in demand for surgical hair transplants.

Other significant reasons boosting the market include an increase in people's disposable money, technological developments in hair treatment medical equipment, and a growing emphasis on looking beautiful. Additionally, the ease of availability of scalp therapy is strengthening the industry.

However, The Europe alopecia treatment market is projected to be hampered by the patent expiration of many blockbuster medications and the adverse effects associated with existing hair loss treatment techniques.

This research report on the European alopecia market has been segmented and sub-segmented into the following categories:

By Disease Type:

  • Alopecia Areata
    • Male
    • Female
  • Cicatricial Alopecia
    • Male
    • Female
  • Traction Alopecia
    • Male
    • Female
  • Alopecia Totalis
    • Male
    • Female
  • Alopecia Universalis
    • Male
    • Female
  • Androgenetic Alopecia
    • Male
    • Female
  • Others
    • Male
    • Female

By Treatment:

  • Pharmaceuticals
  • Devices

By Gender:

  • Male
  • Female

By Sales Channel:

  • Prescriptions
  • OTC

By End Use:

  • Homecare Settings
  • Dermatology Clinics

By Country:

  • United Kingdom
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands and
  • Rest of Europe

Medical diseases such as hyperthyroidism and cancer are the most common causes of alopecia. Every year, the incidence of cancer in the United Kingdom rises. Consumers in Germany are very concerned about their personal appearance and maintenance, and they spend a lot of money on things like hair care. Baldness, on the other hand, is a big problem in the country. According to the German Medical Group, men in Germany are opting for hair transplantation as a result of the rising problem of baldness and hair loss. As a result, these factors are expected to play a key role in driving the alopecia (hair loss) treatment market in Europe during the next several years. In some areas, hair loss has become a frequent problem.

Some countries, such as Germany and France, have a high prevalence of male pattern baldness. As a result, male consumers in the region have a strong demand for hair loss therapy solutions. Furthermore, the region's hair loss treatment goods are driven by an aging population and a shift in lifestyle. Due to the increased demand for these products in the country, the market's leading companies are expanding their facilities and product portfolios in Germany in order to stay competitive.

KEY MARKET PLAYERS:

Johnson & Johnson, Inc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cellmid Ltd., The Himalaya Drug Company, Taisho Pharmaceutical Holdings Co., Ltd, Shiseido Co., Ltd and Zhangguang 101 Science & Technology Co., Ltd are a few of the noteworthy companies in the Europe alopecia treatment market.

1. Introduction                                   

            1.1 Market Definition            

            1.2 Scope of the report                     

            1.3 Study Assumptions                      

            1.4 Base Currency, Base Year and Forecast Periods             

2. Research Methodology                             

            2.1 Analysis Design                

            2.2 Research Phases              

                        2.2.1 Secondary Research     

                        2.2.2 Primary Research          

                        2.2.3 Data Modelling 

                        2.2.4 Expert Validation          

            2.3 Study Timeline                 

3. Report Overview                            

            3.1 Executive Summary                     

            3.2 Key Inferences                 

4. Market Dynamics                           

            4.1 Impact Analysis                

                        4.1.1 Drivers  

                        4.1.2 Restraints          

                        4.1.3 Opportunities   

            4.2 Regulatory Environment              

            4.3 Technology Timeline & Recent Trends                

5. Competitor Benchmarking Analysis                                  

            5.1 Key Player Benchmarking            

                        5.1.1 Market share analysis   

                        5.1.2 Products/Service          

                        5.1.3 Regional Presence        

            5.2 Mergers & Acquisition Landscape                       

            5.3 Joint Ventures & Collaborations              

6. Market Segmentation                                

            6.1 Europe Alopecia Market – By Disease Type:              

                        6.1.1  Alopecia Areata

                        6.1.2 Cicatricial Alopecia       

                        6.1.3 Traction Alopecia          

                        6.1.4 Alopecia Totalis

                        6.1.5 Alopecia Universalis     

                        6.1.6    Androgenetic Alopecia          

                        6.1.7    Others

                        6.1.8 Market Size Estimations & Forecasts (2021-2026)      

                        6.1.9 Y-o-Y Growth Rate Analysis      

                        6.1.10 Market Attractiveness Index  

            6.2 Europe Alopecia Market – By Treatment                   

                        6.2.1 Pharmaceuticals

                        6.2.2    Devices           

                        6.2.3 Market Size Estimations & Forecasts (2021-2026)      

                        6.2.4 Y-o-Y Growth Rate Analysis      

                        6.2.5 Market Attractiveness Index    

            6.3 Europe Alopecia Market – By Gender:                       

                        6.3.1 Male      

                        6.3.2 Female  

                        6.3.3 Market Size Estimations & Forecasts (2021-2026)      

                        6.3.4 Y-o-Y Growth Rate Analysis      

                        6.3.5 Market Attractiveness Index    

            6.4 Europe Alopecia Market – By Sales Channel:             

                        6.4.1  Prescriptions    

                        6.4.2  OTC      

                        6.4.3 Market Size Estimations & Forecasts (2021-2026)      

                        6.4.4 Y-o-Y Growth Rate Analysis      

                        6.4.5 Market Attractiveness Index    

            6.5 Europe Alopecia Market – By End Use:                      

                        6.5.1 Homecare Settings       

                        6.5.2 Dermatology Clinics      

                        6.5.3 Market Size Estimations & Forecasts (2021-2026)      

                        6.5.4 Y-o-Y Growth Rate Analysis      

                        6.5.5 Market Attractiveness Index    

7. Geographical Landscape                            

            7.1 Europe                 

                        7.1.1 By Country        

                                    7.1.1.1 UK

                                    7.1.1.2 France

                                    7.1.1.3 Germany

                                    7.1.1.4 Spain

                                    7.1.1.5 Italy

                                    7.1.1.6 Rest of Europe

                        7.1.2 By Disease Type:           

                        7.1.3 By Treatment:   

                        7.1.4  By Gender:       

                        7.1.5  By Sales Channel:         

                        7.1.6 By End Use:       

8. Key Player Analysis                        

            8.1 Johnson & Johnson, Inc.              

                        8.1.1 Business Description    

                        8.1.2 Products/Service          

                        8.1.3 Financials          

                        8.1.4 SWOT Analysis  

                        8.1.5 Recent Developments  

                        8.1.6 Analyst Overview          

            8.2 Merck & Co., Inc.             

            8.3 Teva Pharmaceutical Industries Ltd.                   

            8.4 Dr. Reddy’s Laboratories Ltd.                  

            8.5 Cipla Ltd.              

            8.6 Cellmid Ltd.                      

            8.7 The Himalaya Drug Company                  

            8.8 Taisho Pharmaceutical Holdings Co., Ltd            

            8.9 Shiseido Co., Ltd              

            8.10  Zhangguang 101 Science & Technology Co., Ltd                      

9. Market Outlook & Investment Opportunities                               

10. Appendix                          

            List of Tables              

            List of Figures    

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and also identify the areas that are still untapped. 

  • The segment-level analysis in terms of disease type, treatment, gender, sales channel, end-use, and region along with market size forecasts and estimations to detect key areas of industry growth in detail.

  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.

  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.

  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.

  • A comprehensive list of key market players along with their product portfolio, current strategic interests, essential financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment.

  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies

  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.

  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations with a strong financial foothold in the market.

  1. Europe Alopecia Market By Disease Type, From 2021 to 2026 ( USD Billion )

  2. Europe Alopecia Market By Treatment, From 2021 to 2026 ( USD Billion )

  3. Europe  Pharmaceuticals Market By Region, From 2021 to 2026 ( USD Billion )

  4. Europe Devices Market By Region, From 2021 to 2026 ( USD Billion )

  5. Europe Alopecia Market By Gender, From 2021 to 2026 ( USD Billion )

  6. Europe Male Market By Region, From 2021 to 2026 ( USD Billion )

  7. Europe Female Market By Region, From 2021 to 2026 ( USD Billion )

  8. Europe Alopecia Market By Sales Channel, From 2021 to 2026 ( USD Billion )

  9. Europe  Prescriptions Market By Region, From 2021 to 2026 ( USD Billion )

  10. Europe  OTC Market By Region, From 2021 to 2026 ( USD Billion )

  11. Europe Alopecia Market By End Use, From 2021 to 2026 ( USD Billion )

  12. Europe Homecare Settings Market By Region, From 2021 to 2026 ( USD Billion )

  13. Europe Dermatology Clinics Market By Region, From 2021 to 2026 ( USD Billion )

  14. U.K. Alopecia Market By Disease Type, From 2021 to 2026 ( USD Billion )

  15. U.K. Alopecia Market By Treatment, From 2021 to 2026 ( USD Billion )

  16. U.K. Alopecia Market By Gender, From 2021 to 2026 ( USD Billion )

  17. U.K. Alopecia Market By Sales Channel, From 2021 to 2026 ( USD Billion )

  18. U.K. Alopecia Market By End Use, From 2021 to 2026 ( USD Billion )

  19. Germany Alopecia Market By Disease Type, From 2021 to 2026 ( USD Billion )

  20. Germany Alopecia Market By Treatment, From 2021 to 2026 ( USD Billion )

  21. Germany Alopecia Market By Gender, From 2021 to 2026 ( USD Billion )

  22. Germany Alopecia Market By Sales Channel, From 2021 to 2026 ( USD Billion )

  23. Germany Alopecia Market By End Use, From 2021 to 2026 ( USD Billion )

  24. France Alopecia Market By Disease Type, From 2021 to 2026 ( USD Billion )

  25. France Alopecia Market By Treatment, From 2021 to 2026 ( USD Billion )

  26. France Alopecia Market By Gender, From 2021 to 2026 ( USD Billion )

  27. France Alopecia Market By Sales Channel, From 2021 to 2026 ( USD Billion )

  28. France Alopecia Market By End Use, From 2021 to 2026 ( USD Billion )

  29. Italy Alopecia Market By Disease Type, From 2021 to 2026 ( USD Billion )

  30. Italy Alopecia Market By Treatment, From 2021 to 2026 ( USD Billion )

  31. Italy Alopecia Market By Gender, From 2021 to 2026 ( USD Billion )

  32. Italy Alopecia Market By Sales Channel, From 2021 to 2026 ( USD Billion )

  33. Italy Alopecia Market By End Use, From 2021 to 2026 ( USD Billion )

  34. Spain Alopecia Market By Disease Type, From 2021 to 2026 ( USD Billion )

  35. Spain Alopecia Market By Treatment, From 2021 to 2026 ( USD Billion )

  36. Spain Alopecia Market By Gender, From 2021 to 2026 ( USD Billion )

  37. Spain Alopecia Market By Sales Channel, From 2021 to 2026 ( USD Billion )

  38. Spain Alopecia Market By End Use, From 2021 to 2026 ( USD Billion )

  39. Europe Alopecia Market By Alopecia Areata, From 2021 to 2026 ( USD Million )

  40. Europe Male Market By Region, From 2021 to 2026 ( USD Million )

  41. Europe Female Market By Region, From 2021 to 2026 ( USD Million )

  42. U.K. Alopecia Market By Alopecia Areata, From 2021 to 2026 ( USD Million )

  43. Germany Alopecia Market By Alopecia Areata, From 2021 to 2026 ( USD Million )

  44. France Alopecia Market By Alopecia Areata, From 2021 to 2026 ( USD Million )

  45. Italy Alopecia Market By Alopecia Areata, From 2021 to 2026 ( USD Million )

  46. Spain Alopecia Market By Alopecia Areata, From 2021 to 2026 ( USD Million )

  47. Europe Alopecia Market By Cicatricial Alopecia, From 2021 to 2026 ( USD Million )

  48. Europe Male Market By Region, From 2021 to 2026 ( USD Million )

  49. Europe Female Market By Region, From 2021 to 2026 ( USD Million )

  50. U.K. Alopecia Market By Cicatricial Alopecia, From 2021 to 2026 ( USD Million )

  51. Germany Alopecia Market By Cicatricial Alopecia, From 2021 to 2026 ( USD Million )

  52. France Alopecia Market By Cicatricial Alopecia, From 2021 to 2026 ( USD Million )

  53. Italy Alopecia Market By Cicatricial Alopecia, From 2021 to 2026 ( USD Million )

  54. Spain Alopecia Market By Cicatricial Alopecia, From 2021 to 2026 ( USD Million )

  55. Europe Alopecia Market By  Traction Alopecia, From 2021 to 2026 ( USD Million )

  56. Europe Male Market By Region, From 2021 to 2026 ( USD Million )

  57. Europe Female Market By Region, From 2021 to 2026 ( USD Million )

  58. U.K. Alopecia Market By  Traction Alopecia, From 2021 to 2026 ( USD Million )

  59. Germany Alopecia Market By  Traction Alopecia, From 2021 to 2026 ( USD Million )

  60. France Alopecia Market By  Traction Alopecia, From 2021 to 2026 ( USD Million )

  61. Italy Alopecia Market By  Traction Alopecia, From 2021 to 2026 ( USD Million )

  62. Spain Alopecia Market By  Traction Alopecia, From 2021 to 2026 ( USD Million )

  63. Europe Alopecia Market By  Alopecia Totalis, From 2021 to 2026 ( USD Million )

  64. Europe Male Market By Region, From 2021 to 2026 ( USD Million )

  65. Europe Female Market By Region, From 2021 to 2026 ( USD Million )

  66. U.K. Alopecia Market By  Alopecia Totalis, From 2021 to 2026 ( USD Million )

  67. Germany Alopecia Market By  Alopecia Totalis, From 2021 to 2026 ( USD Million )

  68. France Alopecia Market By  Alopecia Totalis, From 2021 to 2026 ( USD Million )

  69. Italy Alopecia Market By  Alopecia Totalis, From 2021 to 2026 ( USD Million )

  70. Spain Alopecia Market By  Alopecia Totalis, From 2021 to 2026 ( USD Million )

  71. Europe Alopecia Market By Alopecia Universalis, From 2021 to 2026 ( USD Million )

  72. Europe Male Market By Region, From 2021 to 2026 ( USD Million )

  73. Europe Female Market By Region, From 2021 to 2026 ( USD Million )

  74. U.K. Alopecia Market By Alopecia Universalis, From 2021 to 2026 ( USD Million )

  75. Germany Alopecia Market By Alopecia Universalis, From 2021 to 2026 ( USD Million )

  76. France Alopecia Market By Alopecia Universalis, From 2021 to 2026 ( USD Million )

  77. Italy Alopecia Market By Alopecia Universalis, From 2021 to 2026 ( USD Million )

  78. Spain Alopecia Market By Alopecia Universalis, From 2021 to 2026 ( USD Million )

  79. Europe Alopecia Market By Androgenetic Alopecia, From 2021 to 2026 ( USD Million )

  80. Europe Male Market By Region, From 2021 to 2026 ( USD Million )

  81. Europe Female Market By Region, From 2021 to 2026 ( USD Million )

  82. U.K. Alopecia Market By Androgenetic Alopecia, From 2021 to 2026 ( USD Million )

  83. Germany Alopecia Market By Androgenetic Alopecia, From 2021 to 2026 ( USD Million )

  84. France Alopecia Market By Androgenetic Alopecia, From 2021 to 2026 ( USD Million )

  85. Italy Alopecia Market By Androgenetic Alopecia, From 2021 to 2026 ( USD Million )

  86. Spain Alopecia Market By Androgenetic Alopecia, From 2021 to 2026 ( USD Million )

  87. Europe Alopecia Market By  Others, From 2021 to 2026 ( USD Million )

  88. Europe Male Market By Region, From 2021 to 2026 ( USD Million )

  89. Europe Female Market By Region, From 2021 to 2026 ( USD Million )

  90. U.K. Alopecia Market By  Others, From 2021 to 2026 ( USD Million )

  91. Germany Alopecia Market By  Others, From 2021 to 2026 ( USD Million )

  92. France Alopecia Market By  Others, From 2021 to 2026 ( USD Million )

  93. Italy Alopecia Market By  Others, From 2021 to 2026 ( USD Million )

  94. Spain Alopecia Market By  Others, From 2021 to 2026 ( USD Million )

  95. Europe Alopecia Market By  Others, From 2021 to 2026 ( USD Million )

  96. Europe Male Market By Region, From 2021 to 2026 ( USD Million )

  97. Europe Female Market By Region, From 2021 to 2026 ( USD Million )

  98. U.K. Alopecia Market By  Others, From 2021 to 2026 ( USD Million )

  99. Germany Alopecia Market By  Others, From 2021 to 2026 ( USD Million )

  100. France Alopecia Market By  Others, From 2021 to 2026 ( USD Million )

  101. Italy Alopecia Market By  Others, From 2021 to 2026 ( USD Million )

  102. Spain Alopecia Market By  Others, From 2021 to 2026 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample